Searched for
SUN PHARMA RESULTS
Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...- Stocks in news: Maruti Suzuki, ITC, Vedanta, Swiggy, RILIndian markets traded in a narrow range, settling marginally higher with mixed cues. Maruti Suzuki, ITC, and Vedanta shares are in focus du...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Will Nifty, Sensex fall for 6th straight session on Monday? US Fed among 5 factors to watch this weekIndian equities extended losses for a fifth session amid rising oil prices, persistent FII outflows and geopolitical tensions. Investors no...
- Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeoutIndian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Will Sensex, Nifty extend gains on Monday? Q1 earnings, global tech selloff among 6 factors to steer D-St this weekDalal Street ended the week on a strong note, with the Sensex and Nifty gaining over 1% on Friday. Investors will track six key market trig...
- Why did market rise today? Sensex surges 965 points; Nifty ends above 24,300. 4 reasons why D-Street defied global routIndian stock markets saw gains on Friday, with Sensex and Nifty trading higher. IT stocks led the gains, while broader markets experienced ...
- Rekha Jhunjhunwala sells 1 crore Canara Bank shares in Q1. What's behind the move?Veteran investor Rekha Jhunjhunwala sold over 1.07 crore Canara Bank shares during the April–June quarter, reducing her stake from 1.54% to...
- Rekha Jhunjhunwala likely exits this smallcap metal stock after 90% rally in 1 year. Do you own?Ace investor Rekha Jhunjhunwala has likely exited her investment in Raghav Productivity Enhancers after steadily reducing her stake over re...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- El Nino fear pushes farmers in Srikakulam and Vizianagaram towards water-saving paddy methodsFarmers in Andhra Pradesh's Srikakulam and Vizianagaram districts are shifting to water-saving rice farming techniques. Facing potential El...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
- Sun Pharma Q1 Results: Net profit drops 2% YoY to Rs 2023 croreSun Pharma Q1FY24 net profit fell 2% YoY to Rs 2023 crore due to exceptional items worth Rs 323 crore. However, excluding exceptional items...
- Sun Pharma Q1 Results: Profit surges 43% YoY to Rs 2,061 crore, beats estimatesTotal revenue for the quarter grew 10.73 per cent YoY to Rs 10,761.76 crore compared with Rs 9,718.74 crore in the corresponding quarter la...
- Sun Pharma Q2 Results: Net profit jumps 70% to Rs 1,813 crore, beats St estimatesSun Pharma shares traded 2.78 per cent higher at Rs 482.25 after the announcement of its quarterly results.
Load More
